September 8, 2014

The number of uninsured is expected to decline by nearly half from 45 million in 2012 to 23 million by 2023 as a result of the coverage expansions associated with the Affordable Care Act.

August 19, 2014

Walgreens gifted $350,000 to the University of Maryland School of Pharmacy.

 

August 6, 2014

Amazon.com on Wednesday expanded same-day delivery with new “Get It Today” capabilities.

June 23, 2014

Lupin Pharmaceuticals last week announced the launch of ciprofloxacin oral suspension in 5 g/100 mL (250 mg/5 mL) and 10 g/100 mL (500 mg/5 mL) dosage strengths.

June 11, 2014

Giant Food on Tuesday released a photo delivering $100,000 to USO of Metropolitan Washington-Baltimore.

May 23, 2014

Kroger is planning to expand its footprint into Washington, D.C., and Baltimore under its Harris Teeter banner, according to a report in the Baltimore Business Journal published Thursday.

May 20, 2014

The Centers for Medicare & Medicaid Services on Monday issued final regulations for the Medicare Advantage and prescription drug benefit (Part D) programs.

May 19, 2014

Giant Food is set to host a celebration in honor of the opening of its 50th Peapod Pick-up location across Washington, D.C., Maryland, Virginia and Deleware at the York Road Plaza Giant Food in Baltimore on Tuesday from 11:00 a.m. to noon.

April 21, 2014

Lupin on Monday announced the appointment of Theresa Stevens as chief corporate development officer for its global operations.

April 16, 2014

In celebration of its 150th Express Lane Online Shopping location, which opened last week, the grocer launched a new payment option.

April 16, 2014

Cases of diabetes and pre-diabetes in the United States have nearly doubled since 1988, suggests new research released Tuesday from the Johns Hopkins Bloomberg School of Public Health, with obesity apparently to blame for the surge.

April 10, 2014

Lupin announced that it received final approval from the Food and Drug Administration for pioglitazone tablets USP in 15-mg, 30-mg and 45-mg strengths.

March 28, 2014

Lupin on Thursday announced the acquisition of 100% equity stake in Laboratorios Grin, subject to certain closing conditions.

March 21, 2014

Pharma Major Lupin announced that Lupin Pharmaceuticals, its U.S. subsidiary, has launched niacin extended-release tablets USP in 500-mg, 750-mg and 1,000-mg strengths.

March 14, 2014

The American Pharmacists Association has announced the selection of the 2014 Awards and Honors Program recipients.

March 6, 2014

Lupin on Thursday announced that it received final approval from the Food and Drug Administration for both its doxycycline capsules and its ciprofloxacin for oral suspension.

March 6, 2014

Indie beauty brand Oyin Handmade has announced that, starting in April, its products will be available in select Target stores across the country and online at Target.com.

February 28, 2014

Lupin announced that it received approval from the Food and Drug Administration for rifabutin capsules USP, 150-mg, a generic version of Pharmacia and Upjohn Company's Mycobutin capsules.

December 18, 2013

Lupin has launched a generic drug for treating HIV, following its victory in a patent-infringement suit in federal court, the Indian drug maker said Wednesday.

November 11, 2013

Indian drug maker Lupin has launched its generic version of a drug used to treat gastroesophageal reflux disease, the company said Monday.

November 8, 2013

A study being presented this week at the Annual Scientific Meeting of the American College of Allergy, Asthma and Immunology found hay fever is more prevalent in children living in the southeastern and southern states, ACAAI announced Friday.

October 23, 2013

The University of Maryland's School of Pharmacy has named its atrium in honor of a graduate who now leads an institutional pharmacy services company.

October 22, 2013

Low levels of vitamin D appear to increase a child's risk of anemia, according to new research led by investigators at the Johns Hopkins Children's Center.

October 8, 2013

Lupin Pharmaceuticals announced today that it has launched its generic gatifloxacin ophthalmic solution 0.5%. Lupin had earlier received final approval from the Food and Drug Administration to market a generic version of Allergan's Zymaxid ophthalmic solution, 0.5%, which is indicated for the treatment of bacterial conjunctivitis.